KCI Biotech is a focused preclinical toxicology CRO with deep expertise in non GLP toxicology studies and dose-ranging assessments. Our team integrates toxicology, pathology, and bioanalysis to support efficient toxic dose exploration for small molecules and biologics. We operate advanced, species-capable facilities designed to support all types of preclinical toxicology testing, ensuring reliable data for critical go/no-go decisions. With a proven track record, we provide customized and rapid non GLP toxicology CRO services to de-risk candidates and accelerate your IND-enabling path.
The KCI Early Toxicology Platform operates as a specialized toxicology CRO, delivering rapid and flexible preclinical toxicology testing services. Our non GLP toxicology services are centered on Early toxicology and Toxic Dose Exploration. We conduct single and multiple-dose toxicity studies, acute and long-term non-GLP toxicology studies, local toxicity studies (including sensitization and irritation tests), and toxicokinetics studies to provide crucial safety data during the drug discovery phase. All studies are supported by advanced instrumentation such as Coagulation Analyzers, Biochemical analyzers, and Blood analyzers, ensuring the generation of precise and reliable data throughout your non GLP preclinical studies. This integrated approach helps clients efficiently screen candidate molecules and lays a solid foundation for subsequent GLP-compliant studies and IND filing.| Early toxicology |
| Toxic Dose Exploration |
| Single/multiple dose toxicity studies |
| Acute/long-term toxicity studies |
| Local toxicity studies (sensitization, irritation tests) |
| Toxicokinetics studies |
A: KCI BioTech specializes in Early toxicology and Toxic Dose Exploration, providing key non GLP toxicology studies like acute/long-term tests and toxicokinetics to generate crucial safety data.
A: As an expert preclinical toxicology CRO, we ensure reliable results in non GLP preclinical studies through integrated expertise and advanced analytical instrumentation, supporting your go/no-go decisions.
A: Our toxicology CRO team employs a customized, efficient approach for toxic dose exploration, designed to rapidly de-risk candidate molecules and improve project efficiency.
A: The KCI platform delivers fast, flexible preclinical toxicology testing. Our non GLP toxicology CRO services provide the foundational data needed to confidently advance toward GLP studies and IND filing.
Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china
